Management of Clostridium difficile Infection: Thinking Inside and Outside the BoxGERDING, Dale N; JOHNSON, Stuart.Clinical infectious diseases. 2010, Vol 51, Num 11, pp 1306-1313, issn 1058-4838, 8 p.Article

Clinical Recognition and Diagnosis of Clostridium difficile InfectionBARTLETT, John G; GERDING, Dale N.Clinical infectious diseases. 2008, Vol 46, issn 1058-4838, S12-S18, SUP1Article

Fidaxomicin and the Evolving Approach to the Treatment of Clostridium difficile InfectionGERDING, Dale N; MILLER, Mark A.Clinical infectious diseases. 2012, Vol 55, issn 1058-4838, 107 p., SUP2Serial Issue

Clostridium difficile 30 years on: what has, or has not, changed and why?GERDING, Dale N.International journal of antimicrobial agents (Print). 2009, Vol 33, issn 0924-8579, S2-S8, SUP1Conference Paper

Understanding antimicrobial exposure and Clostridium difficile infection: Implications of fluoroquinolone useBARTLETT, John G; GERDING, Dale N.Clinical infectious diseases. 2008, Vol 46, issn 1058-4838, 54 p., SUP1Serial Issue

Clostridium difficile infection rates and spectrum of disease among peripartum women at one hospital from 2003 to 2007 with molecular typing analysis of recovered Clostridium difficile isolatesVENUGOPAL, Anilrudh A; GERDING, Dale N; JOHNSON, Stuart et al.American journal of infection control. 2011, Vol 39, Num 3, pp 206-211, issn 0196-6553, 6 p.Article

Treatment of Clostridium difficile InfectionGERDING, Dale N; MUTO, Carlene A; OWENS, Robert C et al.Clinical infectious diseases. 2008, Vol 46, issn 1058-4838, S32-S42, SUP1Article

Measures to Control and Prevent Clostridium difficile InfectionGERDING, Dale N; MUTO, Carlene A; OWENS, Robert C et al.Clinical infectious diseases. 2008, Vol 46, issn 1058-4838, S43-S49, SUP1Article

Historical Perspectives on Studies of Clostridium difficile and C. difficile InfectionBARTLETT, John G.Clinical infectious diseases. 2008, Vol 46, issn 1058-4838, S4-S11, SUP1Article

Clostridium difficile Infection and Limitations of Markers for Severity in Patients with Hematologic MalignancyWANG, Michael S; EVANS, Charlesnika T; RODRIGUEZ, Tulio et al.Infection control and hospital epidemiology. 2013, Vol 34, Num 2, pp 127-132, issn 0899-823X, 6 p.Article

Burden of Clostridium difficile on the Healthcare SystemDUBBERKE, Erik R; OLSEN, Margaret A.Clinical infectious diseases. 2012, Vol 55, issn 1058-4838, S88-S92, SUP2Article

Distribution of Clostridium difficile variant toxinotypes and strains with binary toxin genes among clinical isolates in an American hospitalGERIC, Barbara; RUPNIK, Maja; GERDING, Dale N et al.Journal of medical microbiology. 2004, Vol 53, Num 9, pp 887-894, issn 0022-2615, 8 p.Article

Evaluation of an Oral Suspension of VP20621, Spores of Nontoxigenic Clostridium difficile Strain M3, in Healthy SubjectsVILLANO, Stephen A; SEIBERLING, Michael; TATAROWICZ, Walter et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 10, pp 5224-5229, issn 0066-4804, 6 p.Article

Toxin gene analysis of a variant strain of Clostridium difficile that causes human clinical diseaseSAMBOL, Susan P; MERRIGAN, Michelle M; LYERLY, David et al.Infection and immunity. 2000, Vol 68, Num 10, pp 5480-5487, issn 0019-9567Article

Fidaxomicin Is an Inhibitor of the Initiation of Bacterial RNA SynthesisARTSIMOVITCH, Irina; SEDDON, Jaime; SEARS, Pamela et al.Clinical infectious diseases. 2012, Vol 55, issn 1058-4838, S127-S131, SUP2Article

Rifampin plus Metronidazole for Clostridium difficile InfectionDREKONJA, Dimitri M; COHEN, Stuart H; GERDING, Dale N et al.Infection control and hospital epidemiology. 2010, Vol 31, Num 11, issn 0899-823X, p. 1205Article

Frequency of binary toxin genes among Clostridium difficile strains that do not produce large clostridial toxinsGERIC, Barbara; JOHNSON, Stuart; GERDING, Dale N et al.Journal of clinical microbiology (Print). 2003, Vol 41, Num 11, pp 5227-5232, issn 0095-1137, 6 p.Article

Infection of hamsters with epidemiologically important strains of Clostridium difficileSAMBOL, Susan P; TANG, Janet K; MERRIGAN, Michelle M et al.The Journal of infectious diseases. 2001, Vol 183, Num 12, pp 1760-1766, issn 0022-1899Conference Paper

Interruption of Recurrent Clostridium difficile-Associated Diarrhea Episodes by Serial Therapy with Vancomycin and RifaximinJOHNSON, Stuart; SCHRIEVER, Christopher; GALANG, Minerva et al.Clinical infectious diseases. 2007, Vol 44, Num 6, pp 846-848, issn 1058-4838, 3 p.Article

Safety Analysis of Fidaxomicin in Comparison With Oral Vancomycin for Clostridium difficile InfectionsWEISS, Karl; ALLGREN, Robin L; SELLERS, Sarah et al.Clinical infectious diseases. 2012, Vol 55, issn 1058-4838, S110-S115, SUP2Article

Global Epidemiology of Clostridium difficile Infection in 2010GERDING, Dale N.Infection control and hospital epidemiology. 2010, Vol 31, issn 0899-823X, S32-S34, SUP1Conference Paper

Colonization for the prevention of Clostridium difficile disease in hamstersSAMBOL, Susan P; MERRIGAN, Michelle M; TANG, Janet K et al.The Journal of infectious diseases. 2002, Vol 186, Num 12, pp 1781-1789, issn 0022-1899, 9 p.Article

Current State of Clostridium difficile Treatment OptionsVENUGOPAL, Anilrudh A; JOHNSON, Stuart.Clinical infectious diseases. 2012, Vol 55, issn 1058-4838, S71-S76, SUP2Article

A hospital outbreak of Clostridium difficile disease associated with isolates carrying binary toxin genesMCELLISTREM, M. Catherine; CARMAN, Robert J; GERDING, Dale N et al.Clinical infectious diseases. 2005, Vol 40, Num 2, pp 265-272, issn 1058-4838, 8 p.Article

Renal Failure and Leukocytosis Are Predictors of a Complicated Course of Clostridium difficile Infection if Measured on Day of DiagnosisBAUER, Martijn P; HENSGENS, Marjolein P. M; MILLER, Mark A et al.Clinical infectious diseases. 2012, Vol 55, issn 1058-4838, S149-S153, SUP2Article